Abstract
MicroRNAs (miRNAs) are non-encoding, single-stranded RNA molecules of about 22 nucleotides in length encoded by endogenous genes involved in posttranscriptional gene expression regulation. Studies have shown that miRNAs participate in a series of important pathophysiological processes, including the pathogenesis of depression. This article systematically summarized the research results published in the field of miRNAs and depression, which mainly involved three topics: circulating miRNAs as markers for diagnosis and prognosis of depression, the regulatory roles of miRNAs in the pathogenesis of depression, and the roles of miRNAs in the mechanisms of depression treatment. By summarizing and analyzing the research literature in recent years, we found that some circulating miRNAs can be potential biomarkers for the diagnosis and prognostic evaluation of depression. miRNAs that disorderly expressed during the disease play important roles in the depression pathogenesis, and miRNAs also play roles in the mechanisms of psychotherapy and drug therapy for depression. Elucidating the important roles of miRNAs in depression will bring people’s understanding of the pathogenesis of depression to a new level. In addition, these miRNAs may be developed as new biomarkers for diagnosing depression, or as drug targets, or these molecules may be used as new drugs, which may provide new means for the treatment of depression.
Key messages
• The research results of miRNAs and depression are reviewed.
• Circulating miRNAs can be potential biomarkers for depression.
• MiRNAs play important roles in the depression pathogenesis.
• MiRNAs play important roles in drug therapy for depression.
Similar content being viewed by others
Abbreviations
- miRNA:
-
MicroRNA
- CUMS:
-
Chronic unpredictable mild stress
- MDD:
-
Major depression disorder
- PBMCs:
-
Peripheral blood mononuclear cells
- PSD:
-
Poststroke depression
- CNS:
-
Central nervous system
- GR:
-
Glucocorticoid receptor
- BDNF:
-
Brain-derived neurotrophic factor
- CMS:
-
Chronic mild stress
- VLO:
-
Ventrolateral orbital cortex
- DUSP1:
-
Dual-specificity phosphatase 1
- HPA:
-
Hypothalamic-pituitary-adrenal
- Ucn1:
-
Urocortin 1
- CREB:
-
cAMP response element–binding protein
- NMDA:
-
N-Methyl-d-aspartate
- NMDAR-LTD:
-
NMDA receptor–dependent long-term depression
- HDAC4:
-
Histone deacetylase 4
- Sgk1:
-
Serum- and glucocorticoid-inducible protein kinase-1
- PFC:
-
Prefrontal cortex
- RISC:
-
RNA-induced silencing complex
- Ago2:
-
Argounaute-2
- GRM4:
-
Glutamate receptor metabolic type 4
- DDIT4:
-
DNA damage-inducible transcript 4
- SP1:
-
Specificity protein 1
- SERT:
-
Serotonin transporter
- CSF:
-
Cerebrospinal fluid
- SSRI:
-
Selective serotonin reuptake inhibitor
- CSDS:
-
Chronic social defeat stress
- STXBP3A:
-
Syntaxin-binding protein 3
- VAMP1:
-
Vesicle-associated protein 1
- SSd:
-
Saikosaponin d
- BMSCs:
-
Bone marrow mesenchymal stem cells
- FKBP51:
-
FK506-binding protein 51
- CAD:
-
Coronary artery disease
- NOS1:
-
Neuronal nitric oxide synthase 1
- D3R:
-
Dopamine D3 receptor
- DZ:
-
Dingzhi Xiaowan
- CANTAB:
-
Cambridge Neuropsychological Test Automated Battery
- PRM:
-
Pattern recognition memory
- DG:
-
Dentate gyrus
References
Zhu B, Ju S, Chu H, Shen X, Zhang Y, Luo X, Cong H (2018) The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma. Oncol Lett 15:6094–6106
Lu J, Zhan Y, Feng J, Luo J, Fan S (2018) MicroRNAs associated with therapy of non-small cell lung cancer. Int J Biol Sci 14:390–397
Donlic A, Hargrove AE (2018) Targeting RNA in mammalian systems with small molecules. Wiley Interdiscip Rev RNA 9:e1477
Majidinia M, Darband SG, Kaviani M, Nabavi SM, Jahanban-Esfahlan R, Yousefi B (2018) Cross-regulation between Notch signaling pathway and miRNA machinery in cancer. DNA Repair (Amst) 66-67:30–41
Raglan GB, Schulkin J, Micks E (2020) Depression during perimenopause: the role of the obstetrician-gynecologist. Arch Womens Ment Health 23:1–10
Taylor AM, Holscher HD (2020) A review of dietary and microbial connections to depression, anxiety, and stress. Nutr Neurosci 23:237–250
Knight MJ, Baune BT (2018) Cognitive dysfunction in major depressive disorder. Curr Opin Psychiatry 31:26–31
Rosenblat JD, Lee Y, McIntyre RS (2017) Does Pharmacogenomic testing improve clinical outcomes for major depressive disorder? A systematic review of clinical trials and cost-effectiveness studies. J Clin Psychiatry 78:720–729
Maul S, Giegling I, Fabbri C, Corponi F, Serretti A, Rujescu D (2020) Genetics of resilience: implications from genome-wide association studies and candidate genes of the stress response system in posttraumatic stress disorder and depression. Am J Med Genet B Neuropsychiatr Genet 183:77–94
Bennabi D, Haffen E (2018) Transcranial direct current stimulation (tDCS): a promising treatment for major depressive disorder? Brain Sci 8:81–87
Dwivedi Y (2017) MicroRNA-124: a putative therapeutic target and biomarker for major depression. Expert Opin Ther Targets 21:653–656
Lopez JP, Pereira F, Richard-Devantoy S, Berlim M, Chachamovich E, Fiori LM, Niola P, Turecki G, Jollant F (2017) Co-variation of peripheral levels of miR-1202 and brain activity and connectivity during antidepressant treatment. Neuropsychopharmacology 42:2043–2051
Lopez JP, Lim R, Cruceanu C, Crapper L, Fasano C, Labonte B, Maussion G, Yang JP, Yerko V, Vigneault E et al (2014) miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat Med 20:764–768
Roy B, Yoshino Y, Allen L, Prall K, Schell G, Dwivedi Y (2020) Exploiting circulating microRNAs as biomarkers in psychiatric disorders. Mol Diagn Ther 24:279–298
Yoshino Y, Roy B, Dwivedi Y (2020) Altered miRNA landscape of the anterior cingulate cortex is associated with potential loss of key neuronal functions in depressed brain. Eur Neuropsychopharmacol 40:70–84
Yan X, Zeng D, Zhu H, Zhang Y, Shi Y, Wu Y, Tang H, Li D (2020) MiRNA-532-5p regulates CUMS-induced depression-like behaviors and modulates LPS-induced proinflammatory cytokine signaling by targeting STAT3. Neuropsychiatr Dis Treat 16:2753–2764
Enatescu VR, Papava I, Enatescu I, Antonescu M, Anghel A, Seclaman E, Sirbu IO, Marian C (2016) Circulating plasma micro RNAs in patients with major depressive disorder treated with antidepressants: a pilot study. Psychiatry Investig 13:549–557
Yuan H, Mischoulon D, Fava M, Otto MW (2018) Circulating microRNAs as biomarkers for depression: many candidates, few finalists. J Affect Disord 233:68–78
Wang X, Sundquist K, Hedelius A, Palmér K, Memon AA, Sundquist J (2015) Circulating microRNA-144-5p is associated with depressive disorders. Clin Epigenetics 7:69
Gheysarzadeh A, Sadeghifard N, Afraidooni L, Pooyan F, Mofid MR, Valadbeigi H, Bakhtiari H, Keikhavani S (2018) Serum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and miR-1202. J Res Med Sci 23:69
Sun N, Lei L, Wang Y, Yang C, Liu Z, Li X, Zhang K (2016) Preliminary comparison of plasma notch-associated microRNA-34b and -34c levels in drug naive, first episode depressed patients and healthy controls. J Affect Disord 194:109–114
Sun N, Yang C, He X, Liu Z, Liu S, Li X, Wang Y, Jin R, Zhang K (2020) Impact of expression and genetic variation of microRNA-34b/c on cognitive dysfunction in patients with major depressive disorder. Neuropsychiatr Dis Treat 16:1543–1554
Prabu P, Poongothai S, Shanthirani CS, Anjana RM, Mohan V, Balasubramanyam M (2020) Altered circulatory levels of miR-128, BDNF, cortisol and shortened telomeres in patients with type 2 diabetes and depression. Acta Diabetol 57:799–807
Feng J, Wang M, Li M, Yang J, Jia J, Liu L, Zhou J, Zhang C, Wang X (2019) Serum miR-221-3p as a new potential biomarker for depressed mood in perioperative patients. Brain Res 1720:146296
Lian N, Niu Q, Lei Y, Li X, Li Y, Song X (2018) MiR-221 is involved in depression by regulating Wnt2/CREB/BDNF axis in hippocampal neurons. Cell Cycle 17:2745–2755
Gururajan A, Naughton ME, Scott KA, O'Connor RM, Moloney G, Clarke G, Dowling J, Walsh A, Ismail F, Shorten G et al (2016) MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c. Transl Psychiatry 6:e862
He S, Liu X, Jiang K, Peng D, Hong W, Fang Y, Qian Y, Yu S, Li H (2016) Alterations of microRNA-124 expression in peripheral blood mononuclear cells in pre- and post-treatment patients with major depressive disorder. J Psychiatr Res 78:65–71
Kolshus E, Ryan KM, Blackshields G, Smyth P, Sheils O, McLoughlin DM (2017) Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression. Acta Psychiatr Scand 136:594–606
Maffioletti E, Cattaneo A, Rosso G, Maina G, Maj C, Gennarelli M, Tardito D, Bocchio-Chiavetto L (2016) Peripheral whole blood microRNA alterations in major depression and bipolar disorder. J Affect Disord 200:250–258
Wang SS, Mu RH, Li CF, Dong SQ, Geng D, Liu Q, Yi LT (2017) MicroRNA-124 targets glucocorticoid receptor and is involved in depression-like behaviors. Prog Neuropsychopharmacol Biol Psychiatry 79:417–425
Bahi A (2017) Hippocampal BDNF overexpression or microR124a silencing reduces anxiety- and autism-like behaviors in rats. Behav Brain Res 326:281–290
Li D, Wang Y, Jin X, Hu D, Xia C, Xu H, Hu J (2020) NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice. J Neuroinflammation 17:126
Zhao Y, Wang S, Chu Z, Dang Y, Zhu J, Su X (2017) MicroRNA-101 in the ventrolateral orbital cortex (VLO) modulates depressive-like behaviors in rats and targets dual-specificity phosphatase 1 (DUSP1). Brain Res 1669:55–62
Zurawek D, Kusmider M, Faron-Gorecka A, Gruca P, Pabian P, Kolasa M, Solich J, Szafran-Pilch K, Papp M, Dziedzicka-Wasylewska M (2016) Time-dependent miR-16 serum fluctuations together with reciprocal changes in the expression level of miR-16 in mesocortical circuit contribute to stress resilient phenotype in chronic mild stress - an animal model of depression. Eur Neuropsychopharmacol 26:23–36
Song MF, Dong JZ, Wang YW, He J, Ju X, Zhang L, Zhang YH, Shi JF, Lv YY (2015) CSF miR-16 is decreased in major depression patients and its neutralization in rats induces depression-like behaviors via a serotonin transmitter system. J Affect Disord 178:25–31
Shao QY, You F, Zhang YH, Hu LL, Liu WJ, Liu Y, Li J, Wang SD, Song MF (2018) CSF miR-16 expression and its association with miR-16 and serotonin transporter in the raphe of a rat model of depression. J Affect Disord 238:609–614
Lo Iacono L, Ielpo D, Accoto A, Di Segni M, Babicola L, D'Addario SL, Ferlazzo F, Pascucci T, Ventura R, Andolina D (2020) MicroRNA-34a regulates the depression-like behavior in mice by modulating the expression of target genes in the dorsal raphè. Mol Neurobiol 57:823–836
Xie L, Chen J, Ding YM, Gui XW, Wu LX, Tian S, Wu W (2019) MicroRNA-26a-2 maintains stress resiliency and antidepressant efficacy by targeting the serotonergic autoreceptor HTR1A. Biochem Biophys Res Commun 511:440–446
Guo L, Zhu Z, Wang G, Cui S, Shen M, Song Z, Wang JH (2020) microRNA-15b contributes to depression-like behavior in mice by affecting synaptic protein levels and function in the nucleus accumbens. J Biol Chem 295:6831–6848
Deng ZF, Zheng HL, Chen JG, Luo Y, Xu JF, Zhao G, Lu JJ, Li HH, Gao SQ, Zhang DZ et al (2019) miR-214-3p targets β-catenin to regulate depressive-like behaviors induced by chronic social defeat stress in mice. Cereb Cortex 29:1509–1519
Wei YB, Melas PA, Villaescusa JC, Liu JJ, Xu N, Christiansen SH, Elbrønd-Bek H, Woldbye DP, Wegener G, Mathé AA et al (2016) MicroRNA 101b is downregulated in the prefrontal cortex of a genetic model of depression and targets the glutamate transporter SLC1A1 (EAAT3) in vitro. Int J Neuropsychopharmacol 19:pyw069
Aschrafi A, Verheijen JM, Gordebeke PM, Olde Loohuis NF, Menting K, Jager A, Palkovits M, Geenen B, Kos A, Martens GJ et al (2016) MicroRNA-326 acts as a molecular switch in the regulation of midbrain urocortin 1 expression. J Psychiatry Neurosci 41:342–353
Wang M, Guo J, Dong LN, Wang JP (2019) Cerebellar fastigial nucleus stimulation in a chronic unpredictable mild stress rat model reduces post-stroke depression by suppressing brain inflammation via the microRNA-29c/TNFRSF1A signaling pathway. Med Sci Monit 25:5594–5605
Zhao L, Li H, Guo R, Ma T, Hou R, Ma X, Du Y (2013) miR-137, a new target for post-stroke depression? Neural Regen Res 8:2441–2448
Liang HB, He JR, Tu XQ, Ding KQ, Yang GY, Zhang Y, Zeng LL (2019) MicroRNA-140-5p: a novel circulating biomarker for early warning of late-onset post-stroke depression. J Psychiatr Res 115:129–141
Dhar M, Zhu M, Impey S, Lambert TJ, Bland T, Karatsoreos IN, Nakazawa T, Appleyard SM, Wayman GA (2014) Leptin induces hippocampal synaptogenesis via CREB-regulated microRNA-132 suppression of p250GAP. Mol Endocrinol 28:1073–1087
Fiore R, Rajman M, Schwale C, Bicker S, Antoniou A, Bruehl C, Draguhn A, Schratt G (2014) MiR-134-dependent regulation of Pumilio-2 is necessary for homeostatic synaptic depression. EMBO J 33:2231–2246
Tang CZ, Yang JT, Liu QH, Wang YR, Wang WS (2019) Up-regulated miR-192-5p expression rescues cognitive impairment and restores neural function in mice with depression via the Fbln2-mediated TGF-β1 signaling pathway. FASEB J 33:606–618
Tang CZ, Zhang DF, Yang JT, Liu QH, Wang YR, Wang WS (2019) Overexpression of microRNA-301b accelerates hippocampal microglia activation and cognitive impairment in mice with depressive-like behavior through the NF-κB signaling pathway. Cell Death Dis 10:316
Lou D, Wang J, Wang X (2019) miR-124 ameliorates depressive-like behavior by targeting STAT3 to regulate microglial activation. Mol Cell Probes 48:101470
Higuchi F, Uchida S, Yamagata H, Abe-Higuchi N, Hobara T, Hara K, Kobayashi A, Shintaku T, Itoh Y, Suzuki T et al (2016) Hippocampal microRNA-124 enhances chronic stress resilience in mice. J Neurosci 36:7253–7267
Yang W, Liu M, Zhang Q, Zhang J, Chen J, Suo L, Chen Q (2020) Knockdown of miR-124 reduces depression-like behavior in rats by targeting CREB1 and BDNF. Curr Neurovasc Res. 17:196–203
Guo H, Huang B, Wang Y, Zhang Y, Ma Q, Ren Y (2020) Bone marrow mesenchymal stem cells-derived exosomes improve injury of hippocampal neurons in rats with depression by upregulating microRNA-26a expression. Int Immunopharmacol. 82:106285
Cui J, Gong C, Cao B, Li L (2018) MicroRNA-27a participates in the pathological process of depression in rats by regulating VEGFA. Exp Ther Med 15:4349–4355
Su M, Hong J, Zhao Y, Liu S, Xue X (2015) MeCP2 controls hippocampal brain-derived neurotrophic factor expression via homeostatic interactions with microRNA-132 in rats with depression. Mol Med Rep 12:5399–5406
Pei G, Xu L, Huang W, Yin J (2020) The protective role of microRNA-133b in restricting hippocampal neurons apoptosis and inflammatory injury in rats with depression by suppressing CTGF. Int Immunopharmacol. 78:106076
Li C, Wang F, Miao P, Yan L, Liu S, Wang X, Jin Z, Gu Z (2020) miR-138 increases depressive-like behaviors by targeting SIRT1 in hippocampus. Neuropsychiatr Dis Treat 16:949–957
Fonken LK, Gaudet AD, Gaier KR, Nelson RJ, Popovich PG (2016) MicroRNA-155 deletion reduces anxiety- and depressive-like behaviors in mice. Psychoneuroendocrinology 63:362–369
Li Y, Li S, Yan J, Wang D, Yin R, Zhao L, Zhu Y, Zhu X (2016) miR-182 (microRNA-182) suppression in the hippocampus evokes antidepressant-like effects in rats. Prog Neuropsychopharmacol Biol Psychiatry 65:96–103
Xin C, Xia J, Liu Y, Zhang Y (2020) MicroRNA-202-3p targets brain-derived neurotrophic factor and is involved in depression-like behaviors. Neuropsychiatr Dis Treat 16:1073–1083
Jin J, Kim SN, Liu X, Zhang H, Zhang C, Seo JS, Kim Y, Sun T (2016) miR-17-92 cluster regulates adult hippocampal neurogenesis, anxiety, and depression. Cell Rep 16:1653–1663
Gu Z, Pan J, Chen L (2019) MiR-124 suppression in the prefrontal cortex reduces depression-like behavior in mice. Biosci Rep 39:BSR20190186
Roy B, Dunbar M, Shelton RC, Dwivedi Y (2017) Identification of microRNA-124-3p as a putative epigenetic signature of major depressive disorder. Neuropsychopharmacology 42:864–875
Torres-Berrío A, Lopez JP, Bagot RC, Nouel D, Dal Bo G, Cuesta S, Zhu L, Manitt C, Eng C, Cooper HM et al (2017) DCC confers susceptibility to depression-like behaviors in humans and mice and is regulated by miR-218. Biol Psychiatry 81:306–315
Wang Q, Zhao G, Yang Z, Liu X, Xie P (2018) Downregulation of microRNA-124-3p suppresses the mTOR signaling pathway by targeting DDIT4 in males with major depressive disorder. Int J Mol Med 41:493–500
Yang J, Zhang L, Cao LL, Qi J, Li P, Wang XP, Sun XL (2019) MicroRNA-99a is a potential target for regulating hypothalamic synaptic plasticity in the peri/postmenopausal depression model. Cells 8:1081
Miao Z, Mao F, Liang J, Szyf M, Wang Y, Sun ZS (2018) Anxiety-related behaviours associated with microRNA-206-3p and BDNF expression in pregnant female mice following psychological social stress. Mol Neurobiol 55:1097–1111
Bai M, Zhu X, Zhang Y, Zhang S, Zhang L, Xue L, Yi J, Yao S, Zhang X (2012) Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life. PLoS One 7:e46921
Chang CH, Kuek EJW, Su CL, Gean PW (2020) MicroRNA-206 regulates stress-provoked aggressive behaviors in post-weaning social isolation mice. Mol Ther Nucleic Acids 20:812–822
Miguel-Hidalgo JJ, Hall KO, Bonner H, Roller AM, Syed M, Park CJ, Ball JP, Rothenberg ME, Stockmeier CA, Romero DG (2017) MicroRNA-21: expression in oligodendrocytes and correlation with low myelin mRNAs in depression and alcoholism. Prog Neuropsychopharmacol Biol Psychiatry 79:503–514
Zhong X, Cao W, Zhao H, Chen L, Cao J, Wei L, Tang Y, Zhong J, Xiao X, Zu X et al (2020) MicroRNA-32-5p knockout eliminates lipopolysaccharide-induced depressive-like behavior in mice through inhibition of astrocyte overactivity. Brain Behav Immun 84:10–22
Biggar KK, Storey KB (2018) Functional impact of microRNA regulation in models of extreme stress adaptation. J Mol Cell Biol 10:93–101
Liu Q, Zhou J (2019) Effect of miR-16 on behaviors of depression model mice through regulating NF-κB pathway. Minerva Endocrinol 44:397–399
Xu J, Wang R, Liu Y, Liu D, Jiang H, Pan F (2017) FKBP5 and specific microRNAs via glucocorticoid receptor in the basolateral amygdala involved in the susceptibility to depressive disorder in early adolescent stressed rats. J Psychiatr Res 95:102–113
Buran İ, Etem EÖ, Tektemur A, Elyas H (2017) Treatment with TREK1 and TRPC3/6 ion channel inhibitors upregulates microRNA expression in a mouse model of chronic mild stress. Neurosci Lett 656:51–57
Roy B, Dunbar M, Agrawal J, Allen L, Dwivedi Y (2020) Amygdala-based altered miRNome and epigenetic contribution of miR-128-3p in conferring susceptibility to depression-like behavior via Wnt signaling. Int J Neuropsychopharmacol 23:165–177
Serafini G, Trabucco A, Amerio A, Aguglia A, Amore M (2020) Commentary on the study of Roy et al. Amygdala based altered mir-128-3p in conferring susceptibility to depression-like behavior via Wnt signalling. Int J Neuropsychopharmacol 23:178–180
Teo CH, Soga T, Parhar IS (2018) Brain beta-catenin signalling during stress and depression. Neurosignals 26:31–42
Ma K, Xu A, Cui S, Sun MR, Xue YC, Wang JH (2016) Impaired GABA synthesis, uptake and release are associated with depression-like behaviors induced by chronic mild stress. Transl Psychiatry 6:e910
Fang K, Xu JX, Chen XX, Gao XR, Huang LL, Du AQ, Jiang C, Ge JF (2020) Differential serum exosome microRNA profile in a stress-induced depression rat model. J Affect Disord 274:144–158
Wang Q, Roy B, Turecki G, Shelton RC, Dwivedi Y (2018) Role of complex epigenetic switching in tumor necrosis factor-α upregulation in the prefrontal cortex of suicide subjects. Am J Psychiatry 175:262–274
An T, Song Z, Wang JH (2020) Molecular mechanism of reward treatment ameliorating chronic stress-induced depressive-like behavior assessed by sequencing miRNA and mRNA in medial prefrontal cortex. Biochem Biophys Res Commun 528:520–527
Zhang Y, Cheng L, Chen Y, Yang GY, Liu J, Zeng L (2016) Clinical predictor and circulating microRNA profile expression in patients with early onset post-stroke depression. J Affect Disord 193:51–58
Hu J, Zhou W, Zhou Z, Yang Q, Xu J, Dong W (2020) miR-22 and cerebral microbleeds in brainstem and deep area are associated with depression one month after ischemic stroke. Braz J Med Biol Res 53:e9162
Xu C, Liu X, Song X, Gao Q, Cheng L, Wang L, Zhang K, Xu Y (2016) Aberrant resting state in microRNA-30e rat model of cognitive impairment. Neuroreport 27:809–817
Qi S, Yang X, Zhao L, Calhoun VD, Perrone-Bizzozero N, Liu S, Jiang R, Jiang T, Sui J, Ma X (2018) MicroRNA132 associated multimodal neuroimaging patterns in unmedicated major depressive disorder. Brain 141:916–926
Rajgor D, Fiuza M, Parkinson GT, Hanley JG (2017) The PICK1 Ca2+ sensor modulates N-methyl-d-aspartate (NMDA) receptor-dependent microRNA-mediated translational repression in neurons. J Biol Chem 292:9774–9786
Lambert TJ, Storm DR, Sullivan JM (2010) MicroRNA132 modulates short-term synaptic plasticity but not basal release probability in hippocampal neurons. PLoS One 5:e15182
Scott HL, Tamagnini F, Narduzzo KE, Howarth JL, Lee YB, Wong LF, Brown MW, Warburton EC, Bashir ZI, Uney JB (2012) MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex. Eur J Neurosci 36:2941–2948
Zhang HP, Liu XL, Chen JJ, Cheng K, Bai SJ, Zheng P, Zhou CJ, Wang W, Wang HY, Zhong LM et al (2020) Circulating microRNA 134 sheds light on the diagnosis of major depressive disorder. Transl Psychiatry 10:95
Hu Z, Yu D, Gu QH, Yang Y, Tu K, Zhu J, Li Z (2014) miR-191 and miR-135 are required for long-lasting spine remodelling associated with synaptic long-term depression. Nat Commun 5:3263
Taivalantti M, Barnett JH, Halt AH, Koskela J, Auvinen J, Timonen M, Järvelin MR, Veijola J (2020) Depressive symptoms as predictors of visual memory deficits in middle-age. J Affect Disord 264:29–34
Liu Y, Yang X, Zhao L, Zhang J, Li T, Ma X (2016) Increased miR-132 level is associated with visual memory dysfunction in patients with depression. Neuropsychiatr Dis Treat 12:2905–2911
Zheng Z, Zeng Y, Huang H, Xu F (2013) MicroRNA-132 may play a role in coexistence of depression and cardiovascular disease: a hypothesis. Med Sci Monit 19:438–443
Wei ZX, Xie GJ, Mao X, Zou XP, Liao YJ, Liu QS, Wang H, Cheng Y (2020) Exosomes from patients with major depression cause depressive-like behaviors in mice with involvement of miR-139-5p-regulated neurogenesis. Neuropsychopharmacology 45:1050–1058
Sun XH, Song MF, Song HD, Wang YW, Luo MJ, Yin LM (2019) miR-155 mediates inflammatory injury of hippocampal neuronal cells via the activation of microglia. Mol Med Rep 19:2627–2635
Wei YB, Liu JJ, Villaescusa JC, Åberg E, Brené S, Wegener G, Mathé AA, Lavebratt C (2016) Elevation of Il6 is associated with disturbed let-7 biogenesis in a genetic model of depression. Transl Psychiatry 6:e869
Mendes-Silva AP, Fujimura PT, Silva JRDC, Teixeira AL, Vieira EM, Guedes PHG, Barroso LSS, Nicolau MS, Ferreira JDR, Bertola L et al (2019) Brain-enriched microrna-184 is downregulated in older adults with major depressive disorder: A translational study. J Psychiatr Res 111:110–120
Yoshino Y, Roy B, Dwivedi Y (2020) Differential and unique patterns of synaptic miRNA expression in dorsolateral prefrontal cortex of depressed subjects. Neuropsychopharmacology. https://doi.org/10.1038/s41386-020-00861-y
Short AK, Fennell KA, Perreau VM, Fox A, O'Bryan MK, Kim JH, Bredy TW, Pang TY, Hannan AJ (2016) Elevated paternal glucocorticoid exposure alters the small noncoding RNA profile in sperm and modifies anxiety and depressive phenotypes in the offspring. Transl Psychiatry 6:e837
Panta A, Pandey S, Duncan IN, Duhamel S, Sohrabji F (2019) Mir363-3p attenuates post-stroke depressive-like behaviors in middle-aged female rats. Brain Behav Immun 78:31–40
Hung YY, Wu MK, Tsai MC, Huang YL, Kang HY (2019) Aberrant expression of intracellular let-7e, miR-146a, and miR-155 correlates with severity of depression in patients with major depressive disorder and is ameliorated after antidepressant treatment. Cells 8:647
Weigelt K, Bergink V, Burgerhout KM, Pescatori M, Wijkhuijs A, Drexhage HA (2013) Down-regulation of inflammation-protective microRNAs 146a and 212 in monocytes of patients with postpartum psychosis. Brain Behav Immun 29:147–155
Li J, Meng H, Cao W, Qiu T (2015) MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4. Neurosci Lett 606:167–172
Wang X, Wang B, Zhao J, Liu C, Qu X, Li Y (2018) MiR-155 is involved in major depression disorder and antidepressant treatment via targeting SIRT1. Biosci Rep 38:BSR20181139
Wan YQ, Feng JG, Li M, Wang MZ, Liu L, Liu X, Duan XX, Zhang CX, Wang XB (2018) Prefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats. Exp Mol Med 50:1–14
Issler O, Haramati S, Paul ED, Maeno H, Navon I, Zwang R, Gil S, Mayberg HS, Dunlop BW, Menke A et al (2014) MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity. Neuron 83:344–360
Yi LT, Mu RH, Dong SQ, Wang SS, Li CF, Geng D, Liu Q (2018) miR-124 antagonizes the antidepressant-like effects of standardized gypenosides in mice. J Psychopharmacol 32:458–468
Chao B, Huang S, Pan J, Zhang Y, Wang Y (2020) Saikosaponin d downregulates microRNA-155 and upregulates FGF2 to improve depression-like behaviors in rats induced by unpredictable chronic mild stress by negatively regulating NF-κB. Brain Res Bull. 157:69–76
Shimizu S, Tanaka T, Takeda T, Tohyama M, Miyata S (2015) The Kampo medicine Yokukansan decreases microRNA-18 expression and recovers glucocorticoid receptors protein expression in the hypothalamus of stressed mice. Biomed Res Int 2015:797280
Zhu WY, Feng X, Wang J, Lu YP, Dong XZ, Liu P (2018) Effect of Dingzhi Xiaowan on miR-16 expression and 5-HT reuptake. Zhongguo Zhong Yao Za Zhi 43:3513–3518
Lopez JP, Fiori LM, Cruceanu C, Lin R, Labonte B, Cates HM, Heller EA, Vialou V, Ku SM, Gerald C et al (2017) MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes. Nat Commun 8:15497
Maffioletti E, Salvi A, Conde I, Maj C, Gennarelli M, De Petro G, Bocchio-Chiavetto L (2017) Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes. Mol Cell Neurosci 85:220–225
Fiori LM, Lopez JP, Richard-Devantoy S, Berlim M, Chachamovich E, Jollant F, Foster J, Rotzinger S, Kennedy SH, Turecki G (2017) Investigation of miR-1202, miR-135a, and miR-16 in major depressive disorder and antidepressant response. Int J Neuropsychopharmacol 20:619–623
Miao N, Jin J, Kim SN, Sun T (2018) Hippocampal microRNAs respond to administration of antidepressant fluoxetine in adult mice. Int J Mol Sci 19:E671
Patrício P, Mateus-Pinheiro A, Alves ND, Morais M, Rodrigues AJ, Bessa JM, Sousa N, Pinto L (2020) miR-409 and miR-411 modulation in the adult brain of a rat model of depression and after fluoxetine treatment. Front Behav Neurosci 14:136
Kuang WH, Dong ZQ, Tian LT, Li J (2018) MicroRNA-451a, microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment. Braz J Med Biol Res 51:e7212
Fang Y, Qiu Q, Zhang S, Sun L, Li G, Xiao S, Li X (2018) Changes in miRNA-132 and miR-124 levels in non-treated and citalopram-treated patients with depression. J Affect Disord 227:745–751
Zastrozhin S, Petukhov P, Zastrozhina G, Ryzhikova B, Skryabin V, Bryun S (2020) The Influence of concentration of micro-RNA hsa-miR-370-3p and CYP2D6*4 on equilibrium concentration of mirtazapine in patients with major depressive disorder. Psychopharmacol Bull 50:58–75
Bahi A, Dreyer JL (2018) Lentiviral-mediated let-7d microRNA overexpression induced anxiolytic- and anti-depressant-like behaviors and impaired dopamine D3 receptor expression. Eur Neuropsychopharmacol 28:1394–1404
Lin CC, Tsai MC, Lee CT, Sun MH, Huang TL (2018) Antidepressant treatment increased serum miR-183 and miR-212 levels in patients with major depressive disorder. Psychiatry Res 270:232–237
Oved K, Farberov L, Gilam A, Israel I, Haguel D, Gurwitz D, Shomron N (2017) MicroRNA-mediated regulation of ITGB3 and CHL1 is implicated in SSRI action. Front Mol Neurosci 10:355
Fan C, Zhu X, Song Q, Wang P, Liu Z, Yu SY (2018) MiR-134 modulates chronic stress-induced structural plasticity and depression-like behaviors via downregulation of Limk1/cofilin signaling in rats. Neuropharmacology 131:364–376
Yu H, Fan C, Yang L, Yu S, Song Q, Wang P, Mao X (2018) Ginsenoside Rg1 prevents chronic stress-induced depression-like behaviors and neuronal structural plasticity in rats. Cell Physiol Biochem 48:2470–2482
Li HY, Jiang QS, Fu XY, Jiang XH, Zhou QX, Qiu HM (2017) Abnormal modification of histone acetylation involved in depression-like behaviors of rats induced by chronically unpredicted stress. Neuroreport 28:1054–1060
Leff-Gelman P, Mancilla-Herrera I, Flores-Ramos M, Cruz-Fuentes C, Reyes-Grajeda JP, García-Cuétara Mdel P, Bugnot-Pérez MD, Pulido-Ascencio DE (2016) The immune system and the role of inflammation in perinatal depression. Neurosci Bull 32:398–420
Tavakolizadeh J, Roshanaei K, Salmaninejad A, Yari R, Nahand JS, Sarkarizi HK, Mousavi SM, Salarinia R, Rahmati M, Mousavi SF et al (2018) MicroRNAs and exosomes in depression: potential diagnostic biomarkers. J Cell Biochem 119:3783–3797
Bhatt S, Kanoujia J, Dhar AK, Arumugam S, Silva AKA, Mishra N (2020) Exosomes: a novel therapeutic paradigm for treatment of depression. Curr Drug Targets. 22:183–191
Funding
This project was supported by the National Science Foundation of China (No. 81302783), the Anhui Province Key Research and Development Plan (No. 1804a0802218), the Excellent talent project of Anhui Science and Technology University (No.XJYXRC201801), and the special support plan of high-level talent introduction of Anhui University of Chinese Medicine (No. 2020rcZD001).
Author information
Authors and Affiliations
Contributions
This work was completed by Pro. Dr. Chenggui Miao and Dr. Jun Chang. The first author and corresponding author Chenggui Miao is responsible for the idea of the article, literature search, data analysis, drafting, and revising the article. Dr. Jun Chang is mainly responsible for studying and summarizing which circulating miRNAs can be used as potential biomarkers for the diagnosis and prognosis evaluation of depression and assisting the first author to complete the revision of the article.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Miao, C., Chang, J. The important roles of microRNAs in depression: new research progress and future prospects. J Mol Med 99, 619–636 (2021). https://doi.org/10.1007/s00109-021-02052-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-021-02052-8